ClinicalTrialsFinder

EBV-Related Malignant Neoplasm Clinical Trials in Columbus, Ohio

1 recruitingColumbus, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 1

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

EBV-Related Lymphoproliferative DisorderPost-Transplant Lymphoproliferative DisorderChronic Kidney Disease Stage 5+2 more
Ohio State University Comprehensive Cancer Center55 enrolled1 locationNCT06741072